The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Will this trial change my practice? ACCOAST - early loading with a novel P2Y12 inhibitor in patients with an acute coronary syndrome

EuroIntervention 2014;10:408-410. DOI: 10.4244/EIJV10I3A69

1. The Heart Hospital, Cardiology Department, London, United Kingdom; 2. Department of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden; 3. Division of Clinical Epidemiology and Biostatistics, Institu

CABG: coronary artery bypass grafting

CI: confidence interval

DAPT: dual antiplatelet therapy

ESC: European Society of Cardiology

HR: hazard ratio

Hs-TnT: high-sensitivity troponin T

MI: myocardial infarction

NNH/ number needed to harm

NSTE ACS: non-ST elevation acute coronary syndromes

PCI: percutaneous coronary intervention

RRR: relative risk reduction

STEMI: ST elevation myocardial infarction

The contemporary paradigm for managing high-risk NSTE ACS involves an invasive strategy with the use of antithrombotic therapy to reduce ischaemic complications and recurrent adverse cardiovascular events while simultaneously avoiding bleeding complications. Pre-treatment (before ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

Will this trial change my practice? PRAMI - treatment of bystander coronary lesions in patients undergoing primary PCI for acute STEMI